Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.465
-0.035 (-2.33%)
Apr 16, 2026, 2:50 PM EDT - Market open

Pulmonx Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-54-56.39-60.84-58.92-48.66
Depreciation & Amortization
1.051.491.551.510.87
Stock-Based Compensation
21.2322.9622.116.4510.53
Other Adjustments
1.272.112.142.93.72
Change in Receivables
1.08-1.31-3.1-2.19-2.43
Changes in Inventories
-0.77-0.230.92-3.64-6.46
Changes in Accounts Payable
0.272.28-0.350.250.09
Changes in Accrued Expenses
-2.280.463.180.154.8
Changes in Income Taxes Payable
0.19-0.040.07-0.120.02
Changes in Unearned Revenue
-0.120.03-0.02-0.040.09
Changes in Other Operating Activities
-0.3-2.9-3.25-1.42-3.96
Operating Cash Flow
-32.38-31.54-37.61-45.08-41.39
Capital Expenditures
-0.45-1.45-0.81-1.32-3.67
Purchases of Intangible Assets
-0.45-1.45-0.81-1.32-3.67
Purchases of Investments
-5.65-27.91-46.2-47.19-52.58
Proceeds from Sale of Investments
36.5946.844544.2810
Investing Cash Flow
30.4817.48-2.01-4.23-46.26
Long-Term Debt Issued
--20--
Long-Term Debt Repaid
-0.1-0.1-0.09-0.09-
Net Long-Term Debt Issued (Repaid)
-0.1-0.119.91-0.09-
Issuance of Common Stock
11.461.492.594.52
Repurchase of Common Stock
----0.03-0.03
Net Common Stock Issued (Repurchased)
11.461.492.564.5
Other Financing Activities
-0.07---0.05-0.04
Financing Cash Flow
0.831.3621.42.424.46
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-0.090.080.030.150.11
Net Cash Flow
-1.15-12.62-18.18-46.74-83.08
Free Cash Flow
-32.83-32.98-38.42-46.4-45.06
FCF Margin
-36.28%-39.37%-55.94%-86.47%-93.07%
Free Cash Flow Per Share
-0.81-0.84-1.01-1.25-1.25
Levered Free Cash Flow
-56.5-56.84-39.65-63.64-56.88
Unlevered Free Cash Flow
-56.69-58.57-61.23-63.62-55.86
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q